Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics.
CLNN broke resistance
Above 200 EMA
CLNN broke resistance
Above 200 EMA